EORTC 26751.
Methods | RCT | |
Participants | 116 ‐Malignant glioma ‐Optimal resection | |
Interventions | CT + RT vs RT ‐CCNU 130mg/m2 oral % VM‐26 60mg/m2 iv q 6 wks | |
Outcomes | Survival Recurrence‐free survival | |
Notes | 1975‐1978 1st random | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |